1. Home
  2. VSTS vs RARE Comparison

VSTS vs RARE Comparison

Compare VSTS & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vestis Corporation

VSTS

Vestis Corporation

SELL

Current Price

$13.91

Market Cap

1.8B

Sector

N/A

ML Signal

SELL

Logo Ultragenyx Pharmaceutical Inc.

RARE

Ultragenyx Pharmaceutical Inc.

SELL

Current Price

$14.48

Market Cap

1.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
VSTS
RARE
Founded
1936
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2023
2013

Fundamental Metrics

Financial Performance
Metric
VSTS
RARE
Price
$13.91
$14.48
Analyst Decision
Hold
Buy
Analyst Count
8
21
Target Price
$13.00
★ $26.25
AVG Volume (30 Days)
1.4M
★ 5.0M
Earning Date
11-30-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 7.31
EPS
★ 0.05
N/A
Revenue
★ $2,734,839,000.00
$673,000,000.00
Revenue This Year
N/A
$12.87
Revenue Next Year
$1.76
$30.23
P/E Ratio
$288.00
★ N/A
Revenue Growth
N/A
★ 20.13
52 Week Low
$4.81
$12.73
52 Week High
$16.90
$39.89

Technical Indicators

Market Signals
Indicator
VSTS
RARE
Relative Strength Index (RSI) 51.81 38.70
Support Level $13.03 $13.95
Resistance Level $14.93 $15.79
Average True Range (ATR) 0.50 0.70
MACD 0.01 0.35
Stochastic Oscillator 55.46 34.85

Price Performance

Historical Comparison
VSTS
RARE

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

Share on Social Networks: